Skip to main content
. 2024 Jan 4;13(1):283. doi: 10.3390/jcm13010283

Figure 1.

Figure 1

Significant alterations in laboratory markers (absolute changes) in 79 amyloidosis patients after initiation of treatment with SGLT2i. eGFR = estimated glomerular filtration rate. Hs-TropT = high-sensitivity troponin T. PTT = partial thromboplastin time. Hs-TropT was log-transformed (natural logarithm) to approximate for normal distribution. Median follow-up was 8.2 months.